Recombinant Mouse CTLA-4 Fc Chimera Protein 434-CT-200 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Mouse CTLA-4 Fc Chimera Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $504.00Supplier Page View Company Product Page
Catalog Number434-CT-200
SpeciesMouse
Molecule NameCTLA-4
Size200 ug (also 1 mg)
NCBI Full Gene Namecytotoxic T-lymphocyte-associated protein 4
NCBI Gene AliasesCd152, Ly-56, Ctla-4
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular WeightObserved: 55 kDa, reducing conditions
Theoretical: 41 kDa (monomer)
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemNS0-derived Recombinant Mouse CTLA-4 Fc Chimera Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Aire suppresses CTLA-4 expression from the thymic stroma to control autoimmunityCell reportsFebruary 15, 2022Morimoto J, Matsumoto M, Miyazawa R, Yoshida H, Tsuneyama K, Matsumoto M.

(5) Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivoOncoimmunologyJanuary 1, 2014Sandin LC, Eriksson F, Ellmark P, Loskog AS, Tötterman TH, Mangsbo SM.

(6) TIM-3 does not act as a receptor for galectin-9PLoS pathogensMarch 1, 2013Leitner J, Rieger A, Pickl WF, Zlabinger G, Grabmeier-Pfistershammer K, Steinberger P.

(7) Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognitionEuropean journal of immunologyMarch 1, 2013Khan A, Fu H, Tan LA, Harper JE, Beutelspacher SC, Larkin DF, Lombardi G, McClure MO, George AJ.

(8) CD86 is an activation receptor for NK cell cytotoxicity against tumor cellsPloS oneJanuary 1, 2013Peng Y, Luo G, Zhou J, Wang X, Hu J, Cui Y, Li XC, Tan J, Yang S, Zhan R, et al.

CTLA-4 Fc Chimera Protein